Collaborative Applied Research

Registry Studies

A Global Registry of Treatments and Outcomes for Benign Prostatic Hyperplasia

Primary sponsorsSociété Internationale d'Urologie
Secondary sponsors (if any)
Overall study statusPending
Recruitment statusNot yet recruiting

Descriptive Information

Study rationale

Benign prostatic hyperplasia (BPH) is one of the most commonly performed surgical procedures in urology. Over the past few decades, there has been an increasing development of new surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, the SIU is launching a prospective, ongoing international registry to obtain demographics and outcome data from patients undergoing surgical treatments for BPH.

Study objectives
  1. To analyze demographic patterns and baseline characteristics of patients undergoing surgical treatments for BPH
  2. To assess practice patterns (region-specific) for various surgical treatments for BPH
  3. To assess key outcomes (efficacy and safety) for surgical treatments of BPH
Medical conditionBenign Prostatic Hyperplasia with LUTS
Study populationAll patients >18 years with symptomatic BPH with LUTS who are planned for medical or surgical intervention are eligible for this study.
Treatment typeN/A
Primary outcome measures
  1.  IPSS
  2. QOL
  3. Qmax
  4. PVR
  5. Complications (including incontinence)
    1. Type
    2. Clavien grade
  6. SHIM, MSHQ-EJD (optional)
Secondary outcome measures

Recruitment Information

Date of first enrollment
Study start date2022-05-28
Estimated study completion date2025-05-28
Estimated primary completion date2023-05-28

All patients >18 years old with a primary diagnosis of BPH with LUTS that are prescribed medical treatment or a surgical intervention.

Inclusion criteria
  • Patients >18 years old
  • Symptomatic BPH with LUTS
  •  Prescribed medication or surgical intervention for BPH
Exclusion criteria
  • Patients <18 years old
  • Patient with no planned intervention
Primary Facility Contact
First nameMihir
Last nameDesai
Telephone+1 (323) 865-3700
Email[email protected]
Overall Study Officials
First nameMihir
Last nameDesai
DegreeMD, MPH
Organizational affiliationUniversity of Southern California
Official's roleStudy Principal Investigator


Dr. Dean Elterman, Canada
Dr. Mélanie Aubé-Peterkin, Canada
Dr. Reynaldo Gomez, Chile
Prof. Stavros Gravas, Cyprus
Dr. Mauro Gacci, Italy
Prof. Bulent Erkurt, Turkey
Dr. Ranan Dasgupta, United Kingdom
Dr. Mihir Desai, United States


Publication statusPending
If other, please specify
Publication link
Follow Us

Twitter feed